November 20, 2025
1 min read

Indian API maker Cdymax hit with FDA warning letter tied to drug ingredients testing

Cdymax Pharma has been slapped with a warning letter from the FDA outlining two observations against the Bangalore, India-based API maker, both linked to testing shortfalls.

Leave a Reply

Your email address will not be published.

Previous Story

Wildland Firefighters Could Soon Get Mandatory Respiratory Protection

Next Story

Is a bad flu season on the way? Experts see reason to be anxious

Previous Story

Wildland Firefighters Could Soon Get Mandatory Respiratory Protection

Next Story

Is a bad flu season on the way? Experts see reason to be anxious

Latest from Blog

Go toTop